PBFT02 demonstrated durable, elevated CSF PGRN levels and early evidence of reduction in plasma <a target=_blank href= ...

INOVIO , a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today highlighted ...

This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of over 120 biotech and pharma professionals ...

Mathematical modelling, data science and biostatistics specialist Physiomics announced on Wednesday that its Innovate ...

The global artificial intelligence in clinical trials market , valued at US$1.20 billion in 2023, is forecasted to grow at a ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

Artificial intelligence (AI) is transforming the health care landscape, from diagnostics to drug development and clinical trials. As AI ...

Data from the largest US Lyme disease registry suggests that 90% of PLD patients are excluded from clinical trials.

The "AI in Clinical Trials Market by Function, Phase, Indication, Tool, End-User & Region - Global Forecast to 2030" report ...

In the world of drug development, the timing and design of clinical trials can be crucial in getting a new drug to market ...

In this rapidly growing digital era, clinical research operations face increasing complexity, necessitating innovative ...